feed,title,long_url,short_url
SeekingAlpha,Vigil Neuro rises as dosing starts in Phase 1 trial for Alzheimerâ€™s drug,https://seekingalpha.com/news/4021218,
SeekingAlpha,Pros Vs. Cons - Why I'm Passing On Charter Communications,https://seekingalpha.com/article/4641325,
